4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0002015796-26-000002
Options or other derivatives
- Chief Commercial Officer acquired 98,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Olsson Shawn Chief Commercial Officer | 2026-01-02 | Grant or award · Stock Option (right to buy) | +84,200 | 84,200 | D | ||
| Olsson Shawn Chief Commercial Officer | 2026-01-02 | Grant or award · Restricted Stock Unit | +14,000 | 14,000 | D | ||
Loading xslF345X05/wk-form4_1767734519.xml…